Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MARQIBO KIT | Acrotech Biopharma | N-202497 DISCN | 2012-08-09 | 1 products, RLD |
ONCOVIN | Eli Lilly | N-014103 DISCN | 1982-01-01 | 3 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
vincristine sulfate | ANDA | 2024-04-24 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 141 | 394 | 181 | 21 | 36 | 697 |
Leukemia | D007938 | — | C95 | 69 | 161 | 75 | 17 | 22 | 303 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 58 | 141 | 73 | 23 | 23 | 287 |
Lymphoid leukemia | D007945 | — | C91 | 53 | 132 | 61 | 18 | 15 | 248 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 56 | 145 | 52 | 5 | 9 | 233 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 58 | 115 | 56 | 7 | 10 | 217 |
B-cell lymphoma | D016393 | — | — | 65 | 130 | 49 | 6 | 8 | 217 |
Sarcoma | D012509 | — | — | 12 | 42 | 19 | 1 | 10 | 80 |
Follicular lymphoma | D008224 | — | C82 | 19 | 32 | 30 | 2 | 3 | 75 |
T-cell lymphoma | D016399 | — | — | 20 | 41 | 13 | 3 | 4 | 71 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuroblastoma | D009447 | EFO_0000621 | — | 18 | 24 | 16 | — | 4 | 60 |
Central nervous system neoplasms | D016543 | — | — | 9 | 22 | 15 | — | 5 | 49 |
Nervous system neoplasms | D009423 | — | — | 7 | 21 | 13 | — | 5 | 44 |
Ewing sarcoma | D012512 | EFO_0000173 | — | 7 | 23 | 7 | — | 4 | 36 |
Recurrence | D012008 | — | — | 18 | 20 | 1 | — | 2 | 34 |
Rhabdomyosarcoma | D012208 | — | — | 8 | 19 | 12 | — | 2 | 34 |
Multiple myeloma | D009101 | — | C90.0 | 5 | 14 | 13 | — | 1 | 31 |
Plasma cell neoplasms | D054219 | — | — | 3 | 10 | 12 | — | 1 | 26 |
Precursor t-cell lymphoblastic leukemia-lymphoma | D054218 | — | — | 9 | 17 | 5 | — | — | 25 |
Neuroectodermal tumors | D017599 | — | — | 1 | 10 | 7 | — | 3 | 21 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Plasmablastic lymphoma | D000069293 | — | C83.3 | 8 | 7 | — | — | — | 12 |
Large-cell lymphoma immunoblastic | D016400 | — | — | 8 | 7 | — | — | — | 12 |
Aids-related lymphoma | D016483 | EFO_1001365 | — | 4 | 8 | — | — | — | 12 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 3 | 7 | — | — | — | 9 |
Hematologic neoplasms | D019337 | — | — | 5 | 2 | — | — | 2 | 8 |
Blast crisis | D001752 | — | — | 1 | 6 | — | — | — | 7 |
Reactive arthritis | D016918 | EFO_0007460 | M02.3 | — | 6 | — | — | — | 6 |
Lymphoproliferative disorders | D008232 | Orphanet_2442 | D47.9 | 1 | 5 | — | — | — | 6 |
Adult t-cell leukemia-lymphoma | D015459 | — | C91.5 | 3 | 3 | — | — | — | 5 |
Vomiting | D014839 | — | R11.1 | — | 1 | — | — | 3 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pinealoma | D010871 | — | — | 2 | — | — | — | 1 | 3 |
Myelodysplastic-myeloproliferative diseases | D054437 | — | — | 2 | — | — | — | — | 2 |
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 1 | — | — | — | — | 1 |
Deltaretrovirus infections | D006800 | EFO_1001303 | — | 1 | — | — | — | — | 1 |
Htlv-i infections | D015490 | EFO_0007316 | — | 1 | — | — | — | — | 1 |
Composite lymphoma | D058617 | — | — | 1 | — | — | — | — | 1 |
Hematologic diseases | D006402 | EFO_0005803 | D75.9 | 1 | — | — | — | — | 1 |
Mycoses | D009181 | — | B35-B49 | 1 | — | — | — | — | 1 |
Sezary syndrome | D012751 | — | C84.1 | 1 | — | — | — | — | 1 |
Mycosis fungoides | D009182 | — | C84.0 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | — | — | 6 | 6 |
Nausea | D009325 | — | R11.0 | — | — | — | — | 3 | 3 |
Constipation | D003248 | — | K59.0 | — | — | — | — | 2 | 2 |
Cognitive dysfunction | D060825 | — | G31.84 | — | — | — | — | 1 | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | — | — | — | — | 1 | 1 |
Ataxia | D001259 | — | R27.0 | — | — | — | — | 1 | 1 |
Ataxia telangiectasia | D001260 | Orphanet_100 | G11.3 | — | — | — | — | 1 | 1 |
Telangiectasis | D013684 | — | — | — | — | — | — | 1 | 1 |
Cerebellar ataxia | D002524 | — | — | — | — | — | — | 1 | 1 |
Ototoxicity | D000081015 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Vincristine |
INN | vincristine |
Description | Vincristine is a vinca alkaloid with formula C46H56N4O10 found in the Madagascar periwinkle, Catharanthus roseus. It is used (commonly as the corresponding sulfate salt)as a chemotherapy drug for the treatment of leukaemia, lymphoma, myeloma, breast cancer and head and neck cancer. It has a role as a tubulin modulator, a microtubule-destabilising agent, a plant metabolite, an antineoplastic agent and a drug. It is a methyl ester, an acetate ester, a tertiary alcohol, a member of formamides, an organic heteropentacyclic compound, an organic heterotetracyclic compound, a tertiary amino compound and a vinca alkaloid. It is a conjugate base of a vincristine(2+). It derives from a hydride of a vincaleukoblastine. |
Classification | Small molecule |
Drug class | vinca alkaloids |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1 |
PDB | — |
CAS-ID | 57-22-7 |
RxCUI | — |
ChEMBL ID | CHEMBL90555 |
ChEBI ID | 28445 |
PubChem CID | 5978 |
DrugBank | DB00541 |
UNII ID | 5J49Q6B70F (ChemIDplus, GSRS) |